Clinical Trials Browser

Interventional × Restraint, Physical × Endocrine × Clear all

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Phase NA Completed

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary